Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 03:08
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 20°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Deep in Guideline]
MET + SGLT-2i 1Â÷ Ä¡·áÀü·«À¸·Î Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 17:54
[Expert Opinion]
µ¿¾Æ½Ã¾ÆÀο¡ Æ¯ÈµÈ Ç×Ç÷Àü Ä¡·áÀü·« ¾÷µ¥ÀÌÆ®
THE MOST
2021-04-16 17:53
[Interview]
¡°½ÉºÎÀü °ü¸®¿¡¼ SGLT-2¾ïÁ¦Á¦ ¿ªÇÒ Ä¿Áú °Í¡±
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 17:52
[Sub Story]
CKD + °íÇ÷¾Ð SBP 120mmHg ¹Ì¸¸À¸·Î
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 17:52
[Sub Story]
ȯÀÚº° NOAC Á᫐ Ç×ÀÀ°í¿ä¹ý¿¡ ¹«°Ô
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 17:52
¶óÀÎ
[Sub Story]
ACC Àü¹®°¡ÇÕÀǹ®
¡°HFrEF Ä¡·á¿¡ ARNI ¸ÕÀú ¾µ¼öµµ¡±
ÀÌ»óµ· ±âÀÚ
2021-04-16 17:51
[Cover Story]
Ç÷¾Ð¡¤Ç÷´çÁ¶Àý ±âÀüÀ¸·Î ½ÉÀ塤½ÅÀåÁúȯ º® Çã¹®´Ù
ÀÌ»óµ· ±âÀÚ
2021-04-16 17:51
[Sub Story]
RAS¾ïÁ¦Á¦ÀÇ ½ÉºÎÀü¡¤½ÉÇ÷°üÁúȯ ÇýÅÃ
ÀÌ»óµ· ±âÀÚ
2021-04-16 17:46
[Sub Story]
Çѱ¹ÀÎ ½ÉºÎÀü Ä¡·á´Â?
ÀÌ»óµ· ±âÀÚ
2021-04-16 17:25
[Sub Story]
¡°SGLT-2¾ïÁ¦Á¦ ÇÕ·ù´Â ½ÉºÎÀü Ä¡·áÀÇ Áøº¸¡±
ÀÌ»óµ· ±âÀÚ
2021-04-16 17:11
¶óÀÎ
[Sub Story]
Àü±ØµµÀÚÀýÁ¦¼ú ±Ù°Å ¹Ý¿µÀ¸·Î ±Ç°íµî±Þ¡è
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 16:26
[Sub Story]
±¹³» CKD ȯÀÚ 460¸¸¸í ¿¬Æò±Õ 8.7% Áõ°¡ Áß
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 15:45
[Sub Story]
´ç´¢º´ ȯÀÚ Ç÷¾ÐÄ¡·á·Î ½ÅÀåÁúȯ À§Çè±îÁö
ÀÌ»óµ· ±âÀÚ
2021-04-16 11:55
[Sub Story]
ÁýÁß Ç÷´çÁ¶ÀýÀÇ ¹Ì¼¼Ç÷°üÇÕº´Áõ ÇýÅÃ
ÀÌ»óµ· ±âÀÚ
2021-04-16 11:52
[Conference Report]
ÇǸ¶»ç¸£Åº ¡®´Ü¹é´¢ °¨¼Ò¡¯ ÀûÀÀÁõ È®´ë ½ÉÇ÷°ü¡¤½ÅÀ庸ȣȿ°ú Á¤Á¶ÁØ
ÀÌ»óµ· ±âÀÚ
2021-04-16 11:50
¶óÀÎ
[Interview]
½ºÅ¸Æ¾-¿¡Á¦Æ¼¹Ìºê, »óÈ£º¸¿Ï °¡´ÉÇÑ ¡®ÆÄÆ®³Ê¡¯
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 11:41
[Expert Opinion]
¹«Áõ»ó Ãʱ⠰£Áú¼º ÆóÁúȯ ȯÀÚ°ü¸® Á´ãȸ
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 11:26
[Conference Report]
³Ä¡¼º õ½Ä´ë»ó »ý¹°ÇÐÀûÁ¦Á¦¿¡ ÁÖ¸ñ
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 11:08
[Conference Report]
¾Ë·¹¸£±â¼º õ½Ä¿¡µµ »ý¹°ÇÐÀûÁ¦Á¦ °¼¼
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 11:00
[Conference Report]
µÎÇʷ縿, ¾ÆÅäÇǼº ÇǺο° ¾Æ¿ôÄĺÎÅÍ »îÀÇ Áú±îÁö
ÀÓ¼¼Çü ±âÀÚ
2021-04-16 10:49
-
1
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top